Published in Virology on November 01, 1990
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07
The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A (1996) 4.48
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol (1991) 3.94
Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev (1992) 3.60
Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J (1992) 3.25
Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J Virol (1995) 2.76
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol (1995) 1.91
Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 1.80
Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol (1996) 1.69
Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol (1995) 1.62
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol (1992) 1.38
Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. J Virol (2005) 1.36
Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli. J Virol (1994) 1.35
Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev (1996) 1.26
dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol (1997) 1.26
Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication. J Virol (1999) 1.18
Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J Virol (1996) 1.17
Complete nucleotide sequence and transcriptional analysis of snakehead fish retrovirus. J Virol (1996) 1.11
Monoclonal antibodies to conformational epitopes of the surface glycoprotein of caprine arthritis-encephalitis virus: potential application to competitive-inhibition enzyme-linked immunosorbent assay for detecting antibodies in goat sera. Clin Diagn Lab Immunol (2001) 1.08
Variability and immunogenicity of caprine arthritis-encephalitis virus surface glycoprotein. J Virol (2000) 1.07
Transmembrane protein oligomers of caprine arthritis-encephalitis lentivirus are immunodominant in goats with progressive arthritis. J Virol (1992) 1.03
Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritis. J Virol (1994) 1.01
Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication. J Virol (2003) 0.99
Expression in Escherichia coli and sequencing of the coding region for the capsid protein of Dutch maedi-visna virus strain ZZV 1050: application of recombinant protein in enzyme-linked immunosorbent assay for the detection of caprine and ovine lentiviruses. J Clin Microbiol (1991) 0.97
Evaluation of agar gel immunodiffusion serology using caprine and ovine lentiviral antigens for detection of antibody to caprine arthritis-encephalitis virus. J Clin Microbiol (1994) 0.97
Structural and functional analysis of the visna virus Rev-response element. J Virol (1992) 0.97
Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis-encephalitis lentivirus. J Virol (1991) 0.96
Maedi-visna virus and caprine arthritis-encephalitis virus: distinct species or quasispecies and its implications for laboratory diagnosis. Can J Vet Res (1998) 0.95
Competitive-inhibition enzyme-linked immunosorbent assay for detection of serum antibodies to caprine arthritis-encephalitis virus: diagnostic tool for successful eradication. Clin Diagn Lab Immunol (2003) 0.94
Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells. J Virol (2000) 0.93
Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype. J Virol (1999) 0.93
Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (1995) 0.90
Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages. J Virol (1997) 0.88
Structural and functional characterization of rev-like transcripts of equine infectious anemia virus. J Virol (1993) 0.87
Small ruminant lentiviruses: genetic variability, tropism and diagnosis. Viruses (2013) 0.87
Genetic heterogeneity of small ruminant lentiviruses involves immunodominant epitope of capsid antigen and affects sensitivity of single-strain-based immunoassay. Clin Diagn Lab Immunol (2002) 0.86
Molecular characterization and phylogenetic analysis of small ruminant lentiviruses isolated from Canadian sheep and goats. Virol J (2011) 0.86
Analysis of the antibody response to an immunodominant epitope of the envelope glycoprotein of a lentivirus and its diagnostic potential. J Clin Microbiol (2006) 0.85
Use of a recombinant maedi-visna virus protein ELISA for the serologic diagnosis of lentivirus infections in small ruminants. Can J Vet Res (1998) 0.84
The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J Virol (1995) 0.84
Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol (1997) 0.84
Priming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV. J Virol (1998) 0.83
The molecular biology of feline immunodeficiency virus (FIV). Viruses (2011) 0.83
Isolation of maedi/visna virus from a sheep in Japan. J Vet Med Sci (2013) 0.83
Detection of caprine arthritis-encephalitis virus by polymerase chain reaction. J Clin Microbiol (1993) 0.82
Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus. J Virol (1996) 0.81
Conservation of human immunodeficiency virus type 1 gp120 inner-domain sequences in lentivirus and type A and B retrovirus envelope surface glycoproteins. J Virol (2001) 0.81
Host range of small-ruminant lentivirus cytopathic variants determined with a selectable caprine arthritis- encephalitis virus pseudotype system. J Virol (2001) 0.80
Small ruminant lentiviruses (SRLVs) break the species barrier to acquire new host range. Viruses (2013) 0.80
Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV. PLoS One (2008) 0.79
Activation/proliferation and apoptosis of bystander goat lymphocytes induced by a macrophage-tropic chimeric caprine arthritis encephalitis virus expressing SIV Nef. Virology (2007) 0.78
Immunohistology of the early course of lentivirus-induced arthritis. Clin Exp Immunol (1998) 0.77
Small ruminant macrophage polarization may play a pivotal role on lentiviral infection. Vet Res (2013) 0.76
Post-entry blockade of small ruminant lentiviruses by wild ruminants. Vet Res (2016) 0.76
Inducible nitric oxide synthase is expressed in joints of goats in the late stage of infection with caprine arthritis encephalitis virus. Clin Exp Immunol (1999) 0.76
Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein. Retrovirology (2008) 0.75
Impaired Expression of Cytokines as a Result of Viral Infections with an Emphasis on Small Ruminant Lentivirus Infection in Goats. Viruses (2016) 0.75
Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A (1985) 4.66
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science (1985) 4.31
The yeast homologue of U3 snRNA. EMBO J (1987) 3.74
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol (1986) 3.45
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J Virol (1993) 2.65
Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol (1992) 2.30
CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A (1997) 2.23
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol (1995) 2.19
Nucleotide sequence of the jaagsiekte retrovirus, an exogenous and endogenous type D and B retrovirus of sheep and goats. J Virol (1992) 2.13
Biology and pathogenesis of lentiviruses. J Gen Virol (1989) 2.09
High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol (1999) 2.08
LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology (2000) 2.07
Statistics of RNA secondary structures. Biopolymers (1993) 2.06
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Restitution of fibroblast-transforming ability in src deletion mutants of avian sarcoma virus during animal passage. Virology (1979) 1.93
Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology (1993) 1.89
Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol (1997) 1.86
Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol (1996) 1.84
Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol (1997) 1.84
Antigenic variation in visna virus. Cell (1979) 1.81
Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80
Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses. Proc Natl Acad Sci U S A (1986) 1.80
A DNase for apurinic/apyrimidinic sites associated with exonuclease III of Hemophilus influenzae. J Biol Chem (1978) 1.75
cis- and trans-acting transcriptional regulation of visna virus. Science (1985) 1.74
Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A (1989) 1.73
Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis (2001) 1.70
Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. Demonstration of a drug-induced deoxyribonucleic acid-enzyme complex. J Biol Chem (1975) 1.65
The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol (1987) 1.63
Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol (1997) 1.63
A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases. Science (1990) 1.63
A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60
Prep1/Pbx2 complexes regulate CCL2 expression through the -2578 guanine polymorphism. Genes Immun (2008) 1.55
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor. J Virol (1997) 1.55
Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55
Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.53
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology (2001) 1.52
Nucleotide sequence analysis of SA-OMVV, a visna-related ovine lentivirus: phylogenetic history of lentiviruses. Virology (1990) 1.51
Visna virus RNA synthesis. J Virol (1977) 1.48
Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47
Partial enzyme digestion studies on Escherichia coli, Pseudomonas, Chlorella, Drosophila, HeLa and yeast 5S RNAs support a general class of 5S RNA models. J Mol Evol (1977) 1.46
Restricted replication of lentiviruses. Visna viruses induce a unique interferon during interaction between lymphocytes and infected macrophages. J Exp Med (1985) 1.46
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J Virol (1992) 1.43
Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeat. J Virol (1986) 1.43
Interaction between Escherichia coli ribosomal proteins and 5S RNA molecules: recognition of prokaryotic 5S RNAs and rejection of eukaryotic 5S RNAs. Biochimie (1973) 1.41
Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol (1995) 1.39
Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon. J Exp Med (1985) 1.39
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol (1992) 1.38
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38
Genetic structure and function of an early transcript of visna virus. J Virol (1988) 1.37
Genomic organization of the structural proteins of borna disease virus revealed by a cDNA clone encoding the 38-kDa protein. Virology (1993) 1.37
Slow virus-macrophage interactions. Characterization of a transformed cell line of sheep alveolar macrophages that express a marker for susceptibility to ovine-caprine lentivirus infections. Lab Invest (1984) 1.37
Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology (1996) 1.35
CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry (1999) 1.34
Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J Virol (1994) 1.33
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
The synthesis and structure of visna virus DNA. Virology (1979) 1.30
The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol (1996) 1.29
Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol (2004) 1.29
Highly lytic and persistent lentiviruses naturally present in sheep with progressive pneumonia are genetically distinct. J Virol (1984) 1.26
dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol (1997) 1.26
Visna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus. J Virol (1987) 1.24
Multiple coding and the evolutionary properties of RNA secondary structure. J Theor Biol (1993) 1.24
DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J Virol (1999) 1.24
Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses. J Virol (1986) 1.22
Analysis of Borna disease virus-specific RNAs in infected cells and tissues. J Gen Virol (1991) 1.19
Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin Infect Dis (1992) 1.19
Molecular cloning of unintegrated visna viral DNA and characterization of frequent deletions in the 3' terminus. Gene (1983) 1.18
Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis. Virology (1999) 1.17
Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J Virol (1996) 1.17
Biochemical characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.15
Genomic changes associated with antigenic variation of visna virus. II. Common nucleotide sequence changes detected in variants from independent isolations. J Mol Biol (1982) 1.13
Complexity and polyadenylic acid content of visna virus 60-70S RNA. J Virol (1977) 1.13
Conformational analysis of RNA molecules by partial RNAse digestion and two dimensional acrylamide gel electrophoresis. Application to E. coli 5S RNA. Biochimie (1971) 1.12
Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science (1992) 1.12
Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. J Gen Virol (1998) 1.12
Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol Cell Biol (1989) 1.10
Induction of NF-KB during monocyte differentiation by HIV type 1 infection. J Immunol (1991) 1.10
Antigenic variation of molecularly cloned SIVmac239 during persistent infection in a rhesus macaque. Virology (1993) 1.10
Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med (1996) 1.09
Isolation, identification, and partial cDNA cloning of genomic RNA of jaagsiekte retrovirus, the etiological agent of sheep pulmonary adenomatosis. J Virol (1991) 1.09
Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. Virology (2000) 1.08
Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology (1996) 1.06
Properties of visna virus particles harvested at short time intervals: RNA content, infectivity, and ultrastructure. J Virol (1975) 1.06
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J Biol Chem (2001) 1.06
The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J Virol (1989) 1.04
The nucleolus is the site of Borna disease virus RNA transcription and replication. J Virol (1998) 1.04
Precursor polypeptides to structural proteins of visna virus. J Virol (1982) 1.04
SIV infection of macaques--modeling the progression to AIDS dementia. J Neurovirol (1998) 1.03
Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol (2001) 1.01
Lentiviruses of animals are biological models of the human immunodeficiency viruses. Microb Pathog (1988) 1.01
Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience (1993) 1.00